首页>
外国专利>
Method for predicting a subject's risk of contracting diabetes mellitus and / or metabolic syndrome or for diagnosing metabolic syndrome in a subject
Method for predicting a subject's risk of contracting diabetes mellitus and / or metabolic syndrome or for diagnosing metabolic syndrome in a subject
展开▼
机译:预测受试者患糖尿病和/或代谢综合征的风险或诊断受试者代谢综合征的方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
Method for predicting a subject's risk of contracting diabetes mellitus and / or metabolic syndrome or for diagnosing metabolic syndrome in a subject, in which said subject is non-diabetic, comprising the following stages: - determining the level of proneurotensin 1-117 consisting of SEQ ID No. 5 or peptides comprising proneurotensin 1-117 with an immunoassay or determining the level of proneurotensin 1-117 in a body fluid obtained from said subject, wherein said peptides comprising proneurotensin 1-117 are selected from the group comprising SEQ ID No. 1, SEQ ID No. 2, SEQ ID No. 6; and - correlating said level of proneurotensin 1-117 or peptides comprising proneurotensin 1-117 with the risk of said subject of contracting diabetes mellitus and / or metabolic syndrome, in which a high level is predictive of an increased risk of presenting diabetes mellitus and / or metabolic syndrome, or in which an elevated level correlates with the diagnosis of metabolic syndrome in a subject, in which said subject is non-diabetic.
展开▼
机译:预测受试者患有糖尿病和/或代谢综合征或在受试者中诊断代谢综合征的风险的方法,其中所述受试者为非糖尿病患者,其包括以下阶段:-确定由SEQ组成的神经降压素1-117的水平ID 5或包含免疫原性或测定得自所述受试者的体液中神经降压素1-117的水平的包含神经降压素1-117的肽,其中所述包含神经降压素1-117的肽选自包含SEQ ID No.1的组。 1,SEQ ID No.2,SEQ ID No.6; -将神经降压素1-117或包含神经降压素1-117的肽的所述水平与所述受试者患有糖尿病和/或代谢综合征的风险相关联,其中高水平预示存在糖尿病和/或糖尿病的风险增加。或代谢综合征,或其中升高的水平与受试者的代谢综合征的诊断相关,其中所述受试者是非糖尿病的。
展开▼